Jul 19, 2019
Cyxone Makes Further Strides With Rabeximod Phase IIb Trial by Signing CRO EGeen Inc.
Jul 05, 2019
Cyxone Submits First Application to Start Clinical Phase IIb Trial With Rabeximod
Jun 13, 2019
All Primary and Secondary Outcome Targets Met in Mallinckrodt's Phase 4 Acthar® Gel (Repository Corticotropin Injection) Rheumatoid Arthritis (RA) Clinical Trial (n=259) with Data Presented at the European Congress of Rheumatology 2019 (EULAR)
Jun 12, 2019
Global Rheumatoid Arthritis Clinical Trial Pipeline Report 2019-2024 - Track Competition, Identifying Partners, & Evaluate Opportunities
Jun 12, 2019
New Long-Term Data from Upadacitinib Phase 3 Studies in Rheumatoid Arthritis Including Results on Clinical Remission at 48 Weeks Presented at EULAR
Jun 10, 2019
Rheumatoid Arthritis - Can its Onset be Delayed or Prevented
May 29, 2019
Mallinckrodt Announces Positive Open-Label Results from Phase 4 Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Rheumatoid Arthritis (RA) to be Presented at the European Congress of Rheumatology 2019 (EULAR)
May 08, 2019
HSS Researchers Advance Understandings of the Cellular Mechanisms Driving Rheumatoid Arthritis
May 02, 2019
Spondylitis Association of America Launches Global Spondyloarthritis Summit to Raise Awareness of Painful Rheumatic Disease
May 02, 2019
Mallinckrodt to Present Open-Label Results from Phase 4 Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis at Annual European Congress of Rheumatology (EULAR 2019)
Apr 16, 2019
Non-invasive vagus nerve stimulation shows promise for treatment of rheumatoid arthritis
Apr 01, 2019
Rheumatoid Arthritis Drugs Market to Record a CAGR of Approx 10.5% During 2019-2024
Mar 15, 2019
Information Update - Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)
Feb 19, 2019
AbbVie Announces New Drug Application Accepted for Priority Review by U.S. FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
Feb 06, 2019
The global rheumatoid arthritis drugs market will reach $47bn in 2024
Feb 05, 2019
Mallinckrodt Provides Update on Phase 4 Data H.P. Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis (RA)
Feb 04, 2019
Global Rheumatoid Arthritis Competitor Landscape Report 2018-2019YE
Jan 29, 2019
imaware(TM) Partners with Rheumatoid Patient Foundation to Promote Awareness and Early Diagnosis of Rheumatoid Arthritis
Jan 24, 2019
Amgen And Allergan Announce Positive Top-Line Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab
Jan 24, 2019
Global Rheumatoid Arthritis Therapeutics Market 2019-2025: Preference for Combination Therapies Growing Demand for JAK Inhibitors, Anti-ACPAs for Clinical Diagnosis, FDA Approval of Auto-Injector